The development of advanced human-derived in vitro models is critical for enhancing the predictive power of biological research. Human primary cells, coculture systems, and vascularized 3D models now provide more physiologically relevant environments that address limitations of traditional cell-based assays, enabling more accurate insight into tissue architecture, disease mechanisms, and drug responses.
In this webinar, Scott Kelsey, Kevin Grady, and Christopher Hughes will discuss approaches for constructing robust angiogenesis models and the application of vascularized organ and tumor chip platforms in drug discovery.
Topics to be covered:
- Principles and best practices for using primary human cells in screening and testing
- Strategies for building biologically relevant coculture and 3D models
- The role of vascularization in enhancing model predictivity
- Applications of vascularized organ and tumor chips for more accurate drug screening
Tuesday, January 13th, 2026 | 11:00 AM – 1:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speakers
Scott Kelsey
Senior Technical Support Specialist, R&D
Lonza
Kevin Grady
Associate Director, Marketing Strategy
Lonza
Christopher Hughes, PhD
CSO and Co-Founder
Aracari Biosciences
